JESSICA GEIMAN: Open Payments
NPI 1134964588 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 30 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,537 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 4 | $87 |
| ABBVIE INC. | 3 | $67 |
| UCB, Inc. | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Eisai Inc. | 2 | $47 |
| PFIZER INC. | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Neurelis, Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $27 |
Products named: LEQEMBI, REXULTI, NURTEC ODT, AUSTEDO XR, Rystiggo, VALTOCO, BOTOX, UBRELVY.
Industry payments across VA — which companies pay providers there.
